Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine
Authors
Keywords
-
Journal
Clinical and Vaccine Immunology
Volume 18, Issue 8, Pages 1358-1364
Publisher
American Society for Microbiology
Online
2011-06-30
DOI
10.1128/cvi.05111-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses
- (2011) Jiri Beran et al. CLINICAL THERAPEUTICS
- Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea
- (2011) Joon Young Song et al. VACCINE
- AS03A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age
- (2010) François Roman et al. CLINICAL INFECTIOUS DISEASES
- MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
- (2010) Hana El Sahly Expert Review of Vaccines
- Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
- (2010) Karl G Nicholson et al. LANCET INFECTIOUS DISEASES
- Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea
- (2010) Hee Jin Cheong et al. VACCINE
- Emulsion-based adjuvants for influenza vaccines
- (2009) Frederick R Vogel et al. Expert Review of Vaccines
- Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
- (2009) Eric Plennevaux et al. LANCET
- In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses
- (2009) Yasushi Itoh et al. NATURE
- Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
- (2009) Michael E. Greenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Influenza A (H1N1) Vaccine in Various Age Groups
- (2009) Feng-Cai Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
- (2009) Tristan W. Clark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
- (2009) Kathy Hancock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial
- (2009) François Roman et al. VACCINE
- Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine
- (2008) H. Keipp Talbot et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More